Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-053850
Filing Date
2004-03-30
Accepted
2004-03-30 15:56:14
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 957233
3 LEASE DATED DECEMBER 12, 2003 BETWEEN GLYCOGENESYS, INC. AND ONE KENDALL SQ. dex101.htm EX-10.1 377257
4 GLYCOGENESYS, INC. CODE OF BUSINESS ETHICS AND CONDUCT dex141.htm EX-14.1 86345
5 LIST OF SUBSIDIARIES dex21.htm EX-21 1930
6 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 2022
7 CONSENT OF DELOITTE & TOUCHE LLP dex232.htm EX-23.2 1979
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 7299
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 7269
10 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4683
11 GRAPHIC g39185g57v08.jpg GRAPHIC 89014
  Complete submission text file 0001193125-04-053850.txt   1538116
Mailing Address 31 ST JAMES AVE 8TH FL BOSTON MA 02116
Business Address 31 ST. JAMES AVENUE 8TH FLOOR BOSTON MA 02116 6174220674
GLYCOGENESYS INC (Filer) CIK: 0000946661 (see all company filings)

EIN.: 330231238 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26476 | Film No.: 04700981
SIC: 2836 Biological Products, (No Diagnostic Substances)